Skip to main content

Table 1 Baseline information on patients with IgG4-RS

From: Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents

Characteristic

Value

Age (years)

51.8 ± 14.4

Male:female ratio

0.54:1

Enlargement of major salivary glands

 SMG

Bilateral, n (%)

42 (97.7)

Unilateral, n (%)

1 (2.3)

 PG

Bilateral, n (%)

30 (69.8)

Unilateral, n (%)

3 (7.0)

 Sublingual gland, n (%)

30 (69.7)

 Accessory parotid gland, n (%)

7 (16.3)

Extra-salivary involvement, n (%)

39 (90.7)

 Enlargement of lacrimal gland, n (%)

31 (72.1)

 Enlargement of cervical lymph nodes, n (%)

33 (76.7)

 Rhinosinusitis, n (%)

22 (51.2)

 Asthma, n (%)

2 (4.7)

 Autoimmune pancreatitis, n (%)

2 (4.7)

 Interstitial pneumonia, n (%)

2 (4.7)

 Sclerosing cholangitis, n (%)

1 (2.3)

Elevated serum IgG4 level, n (%)

42 (97.7)

  1. IgG4-RS IgG4-related sialadenitis, SMG submandibular gland, PG parotid gland